Grand Solutions: Life science, health and welfare technology

With investments within this call, Innovation Fund Denmark will support that Denmark’s strong knowledge and research position within the field is transformed into inventions, products, and technologies, which benefit Denmark. This call consists of two parts.

Who?

Enterprises, research institutions or public institutions in or outside Denmark, directly involved in the project activities, is eligible to apply, participate and receive funding from Innovation Fund Denmark

What?

Co-financing of expenses for e.g. salaries, equipment, other project-related costs, external services, etc. (see section 1.5 in the Grand Solutions guidelines published end of January 2022 for further information)

How much?

Part A: Life science, health and welfare technology: Minimum 127.4 mill. DKK.*. Investment per project (within part A): from 5 mill. to 40 mill. DKK.
Part B: Stem cell research center: 24.5 mill. DKK.

Important dates

February 1, 2022

Opens for applications

April 5, 2022

Application deadline

November 2022

Response to application

Early 2023

Project start

 

The Grand Solutions programme invests in ambitious, and preferably, interdisciplinary research and innovation projects that can create new, specific solutions to important, politically prioritized societal challenges and create value throughout Denmark.

To the extent possible, the Grand Solutions programme invests in projects that are carried out in close collaboration between research institutions and the business community.

 

Aim of the call

This call consists of the following parts:

A. Life science, health and welfare technology
At least DKK 127.4 million *

B. Stem Cell Research Center
24.5 million DKK

* With the possibility of transferring funds from Innovation Fund Denmark’s other programmes. The potential transfer of funds can concretely result in an increased budget.

Applicants must submit their application under part A (Life science, health and welfare technology) or part B (Stem cell research center). If the applicant submits the application under part B, and the application meets the formal requirements for the application as specified in the guidelines for Grand Solutions, but nevertheless does not receive an investment, the application will subsequently automatically be considered under part A and will be processed here in the same way as other applications. This is because part A is the general part of the call, while part B is a specific part of the call, which is thematically contained in part A. If the applicant submits the application under part A, and the Innovation Fund Denmark assesses that the application also falls within the framework of part B, the Innovation Fund Denmark may choose to process the application under part B first.

A. Life science, health and welfare technology

With investments within ”Life science, health, and welfare technology”, Innovation Fund Denmark will support that Denmark’s strong knowledge and research position within the field is transformed into inventions, products, and technologies which benefit citizens in Denmark, healthcare sectors, the companies’ net income, and Danish exports. The funds must contribute to creating societal value and economic growth for private and public companies and/or consumers in the society, not least in the life science sector. As far as possible, the research must therefore be carried out in close interaction between research institutions and the business community.

The research can e.g. contribute to the development of personalised medicine, the development of the digital health area, including the health data area, artificial intelligence, and digital prevention and treatment options for people with mental illness, as well as knowledge about the use of medical cannabis.

The projects can support the development of local business powerhouses (in Danish: “erhvervsfyrtårne”) (see link in section 5: “Guidelines and inspiration”)

B. Stem cell research center

Innovation Fund Denmark also invests 24.5 mill. DKK to a center within stem cell research with significant international research and co-financing from public and private actors.

 

Evaluation

The three overall decision criteria are:

  • Quality of the idea – the quality of the research and innovation
  • Impact – value creation during and after the project
  • Quality of execution – efficiency in the project execution and the implementation of the results

Further information about the decision criteria can be found in the guidelines for Grand Solutions, which will be published on Innovation Fund Denmark’s website at the end of January 2022 (see link in section 5: “Guidelines and inspiration”)

It is emphasized that key stakeholders of the project contributes to develop the project and participates in, or in other ways are directly involved in the project, e.g. through investment.

In addition to the three decision criteria, reference is made to the guidelines for Grand Solutions. The distribution of the funds originates from the current Finance Act and the agreement on the disposition of the Research Reserve (see links under section 5: “Guidelines and inspiration”).

 

Evaluation Process

Applications to Grand Solutions must be submitted via www.e-grant.dk, which is the application portal of Innovation Fund Denmark. The call open in e-grant on February 1, 2022. Please note, that applicants will receive a receipt for submitting the application if the application is submitted after mid March 2022.

The evaluation process is described in detail in the guidelines for Grand Solutions and briefly outlined below.

Evaluation process

Open model as PDF

Applicants are notified of the decision via www.e-grant.dk. E-grant has prepared a FAQ that can be accessed here.

It is expected that the project applications proceeding to phase 2, will receive either invitation for investment negotiations or rejection of application in November 2022, after which the investment negotiations can be initiated with an expected project start in the beginning of 2023.

More info

Advice and guidance

Questions and answers

Contact

The program

Application

Evaluation

From approval to project start

During the project

Process in case of missing consultation

Process in case of lack of recognized researcher

Sammenligning af EUDP- og Grand Solution-programmer

This page is not available in English. You’ll remain on the Danish version of the page.